How can sequential therapy be used in castration-resistant prostate cancer?
by Gerald Mickisch
Clinical implications of CTCs in prostate cancer – are they the best thing to measure?
by Susanne Osanto
Advanced prostate cancer treatment – if, when and what?
by Axel Merseburger
Prostate cancer update: practice-changing data?
by Rob Jones
Update on Study 19 trial of olaparib in serous ovarian cancer
by Jonathan Ledermann